Results per Page:
Extrachromosomal DNA contributes to cancerous transformation of Barrett’s esophagus
From Thomas Paulson and the Reid Lab, Clinical Research and Translational Science and Therapeutics Divisions
New study identifies genetic changes in patients who progress to esophageal cancer
Findings in precancerous Barrett’s esophagus a step toward improved screening, prevention
Esophageal adenocarcinoma: when DNA methylation informs the treatment
from the Grady lab, Clinical Research Division
Researchers identify four genetic variants that are linked to esophageal cancer and its precursor, Barrett’s esophagus - Fred Hutchinson Cancer Research Center
Findings from the first large-scale, genome-wide association study of esophageal adenocarcinoma may lead to new screening tools for those at high risk
Hutchinson Center researcher secures $7.9 million NCI grant for esophageal cancer research
Study to evaluate genetic risk for Barrett’s esophagus and esophageal adenocarcinoma
Aspirin significantly reduces esophageal-cancer risk in people with most-aggressive form of Barrett's esophagus
Study also identifies biomarkers that predict which patients are most likely to get cancer